Anaplasia

Anaplasia is a term used in medicine to describe cells that have lost their normal structure and function. These cells are often found in tumors (cancers). They are considered abnormal and can grow uncontrollably.

Condition

What people with Anaplasia report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Anaplasia

What It Is

Anaplasia is a term pathologists use when cancer cells have lost the features of the normal cells they came from. Under a microscope, anaplastic cells bear little resemblance to normal tissue: they can have greatly enlarged, dark-staining nuclei and divide in abnormal ways. Their usual structure and function are largely gone, which is why they are also described as undifferentiated. Anaplasia is not a separate disease. It is a finding within a specific cancer, and its meaning depends on which cancer that is. In general, cancer cells that look very abnormal tend to grow and spread faster than cells that still resemble normal tissue. The word also appears in the names of some cancers, such as anaplastic thyroid cancer, where the whole tumor is made of undifferentiated cells.

Causes & Risk Factors

Anaplasia is not caused by something a person did or was exposed to on a particular day. It reflects genetic changes that build up inside tumor cells as a cancer develops. In some cancers, anaplastic areas seem to appear later, from a group of tumor cells that has acquired additional genetic changes beyond those that started the cancer. The risk factors that matter are those of the underlying cancer, such as radiation exposure for thyroid cancer or certain inherited syndromes for childhood kidney tumors. In Wilms tumor, a childhood kidney cancer, anaplasia is more common in older children (aged 10 to 16) than in younger ones.

How It's Diagnosed

Anaplasia can only be identified by looking at tissue. A doctor takes a sample through a biopsy or removes the tumor in surgery, and a pathologist (a doctor who diagnoses disease by examining cells and tissues) studies it under a microscope. The findings go into a pathology report, often as part of the tumor grade. Grade describes how abnormal the cells look. Many cancers are graded from 1 to 4: grade 1 cells look close to normal (well differentiated), while grade 3 and 4 cells look poorly differentiated or undifferentiated, which is where anaplasia fits. Grade is different from stage, which describes how large the tumor is and how far it has spread. Both shape treatment. Some cancers have specific rules. In Wilms tumor, the pathologist looks for greatly enlarged, dark-staining nuclei and abnormal cell divisions, and reports whether anaplasia is focal (confined to one or more sharply limited areas) or diffuse (more widespread). Molecular tests on the tumor are often done alongside, because some results open specific treatment options.

Treatment Options

There is no treatment aimed at anaplasia itself. Treatment targets the cancer, and the finding of anaplasia helps the care team decide how intensive that treatment should be. Because high-grade, anaplastic tumors can grow and spread quickly, they often call for prompt and more aggressive treatment. The plan still depends on the cancer type, its stage, the tumor's genetic features, and the person's age and general health. In Wilms tumor, anaplastic tumors respond less well to the chemotherapy used for the more common, favorable type. Children with anaplasia, particularly diffuse anaplasia, usually receive additional chemotherapy medicines and often radiation therapy after surgery, with the intensity set by stage and by whether the anaplasia is focal or diffuse. In anaplastic thyroid cancer, the tumor should be tested for a change in BRAF, a gene that helps control cell growth. When a specific BRAF change (called V600E) is present and surgery or radiation to the neck cannot control the cancer, the targeted pills dabrafenib (Tafinlar) and trametinib (Mekinist), which block growth signals in the cancer cells, are used together. Surgery, radiation, other drug treatment and supportive care to protect breathing and swallowing may also be part of care. Clinical trials are an option for many anaplastic cancers.

What to Expect

What anaplasia means for the future depends heavily on the cancer it is found in, so there is no single outlook. In general, it signals a cancer that may behave more aggressively and may need closer follow-up than a well-differentiated cancer of the same type at the same stage. The pattern matters too. In Wilms tumor, anaplasia is the most important microscopic predictor of how well treatment works, but focal anaplasia carries a better outlook than diffuse anaplasia, and many children with anaplastic tumors, especially at early stages, still do well with today's more intensive treatment. Anaplastic thyroid cancer, by contrast, is rare but very serious: it usually has already spread within the neck when it is found, so care often focuses both on controlling the cancer and on comfort and quality of life. More intensive treatment can mean more side effects, more appointments and a longer course of therapy. Follow-up scans and visits continue after treatment to watch for the cancer returning.

When to Seek Help

If a pathology report mentions anaplasia, anaplastic features or undifferentiated cells, arrange to go over it with your oncologist or the doctor who ordered the biopsy, rather than interpreting it alone from a patient portal. Ask how it affects the treatment plan. During or after treatment, contact the care team promptly about a new lump, swelling or pain at or near the tumor site, or new symptoms the team asked you to watch for. For someone with a tumor in the neck, such as anaplastic thyroid cancer, new or worsening trouble swallowing or breathing needs a call to the care team right away, and breathing that is quickly becoming difficult needs emergency care.

Questions to Ask Your Doctor

  1. 1.What does anaplasia mean for my type of cancer, and is it focal or widespread in my tumor?
  2. 2.How does this finding change the treatment you recommend compared with a lower-grade tumor?
  3. 3.Has the tumor had molecular testing, such as for BRAF, and could any result open a targeted treatment or clinical trial?
  4. 4.Would a second opinion from another pathologist be useful in my case?
  5. 5.What follow-up schedule should I expect after treatment, and which symptoms should I report?

Last reviewed • Oct 2026

Educational content, not medical advice.